These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24992138)

  • 21. More on Lorenzo's oil.
    Odone A; Odone M
    N Engl J Med; 1994 Jun; 330(26):1904-5. PubMed ID: 8196741
    [No Abstract]   [Full Text] [Related]  

  • 22. Positive effects with Lorenzo's oil.
    Siva N
    Lancet Neurol; 2005 Sep; 4(9):529. PubMed ID: 16136703
    [No Abstract]   [Full Text] [Related]  

  • 23. Profound thrombocytopenia complicating dietary erucic acid therapy for adrenoleukodystrophy.
    Crowther MA; Barr RD; Kelton J; Whelan D; Greenwald M
    Am J Hematol; 1995 Feb; 48(2):132-3. PubMed ID: 7847331
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of Lorenzo's Oil on peroxisomes in healthy mice.
    De Craemer D; Van den Branden C; Fontaine M; Vamecq J
    Prostaglandins Other Lipid Mediat; 1998 Mar; 55(4):237-44. PubMed ID: 9644114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lorenzo's oil. A realistic presentation of two parents' fight against adrenoleukodystrophy].
    Söderfeldt B
    Lakartidningen; 1993 May; 90(20):1969-72. PubMed ID: 8502039
    [No Abstract]   [Full Text] [Related]  

  • 26. Lorenzo's oil--hope and disappointment.
    Rizzo WB
    N Engl J Med; 1993 Sep; 329(11):801-2. PubMed ID: 8043042
    [No Abstract]   [Full Text] [Related]  

  • 27. Lorenzo's oil: a reassessment.
    Poulos A; Robertson EF
    Med J Aust; 1994 Mar; 160(6):315-7. PubMed ID: 8133809
    [No Abstract]   [Full Text] [Related]  

  • 28. Is subclinical adrenal failure in adrenoleukodystrophy/adrenomyeloneuropathy reversible?
    Cappa M; Bizzarri C; Giannone G; Aiello C; Di Biase A
    J Endocrinol Invest; 2011 Nov; 34(10):753-6. PubMed ID: 21399389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A hierarchical Bayesian approach for combining pharmacokinetic/pharmacodynamic modeling and Phase IIa trial design in orphan drugs: Treating adrenoleukodystrophy with Lorenzo's oil.
    Basu C; Ahmed MA; Kartha RV; Brundage RC; Raymond GV; Cloyd JC; Carlin BP
    J Biopharm Stat; 2016; 26(6):1025-1039. PubMed ID: 27547896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A happier sequel to Lorenzo's Oil?
    Wanders RJ
    Nat Med; 1998 Nov; 4(11):1245-6. PubMed ID: 9809546
    [No Abstract]   [Full Text] [Related]  

  • 31. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
    Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C
    N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Exogenous lipid pneumonia with hyperpyrexia: a case report].
    Wu XJ; Li M; Zhan QY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):921-923. PubMed ID: 30337759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exogenous lipoid pneumonia induced by nasal instillation of paraffin oil.
    Bartosiewicz M; Zimna K; Lewandowska K; Sobiecka M; Dybowska M; Radwan-Rohrenschef P; Szturmowicz M; Tomkowski W
    Adv Respir Med; 2019; 87(6):254-257. PubMed ID: 31970727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials.
    Moser HW; Raymond GV; Koehler W; Sokolowski P; Hanefeld F; Korenke GC; Green A; Loes DJ; Hunneman DH; Jones RO; Lu SE; Uziel G; Giros ML; Roels F
    Adv Exp Med Biol; 2003; 544():369-87. PubMed ID: 14713253
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipoid pneumonia--a case of refractory pneumonia in a child treated with ketogenic diet.
    Buda P; Wieteska-Klimczak A; Własienko A; Mazur A; Ziołkowski J; Jaworska J; Kościesza A; Dunin-Wąsowicz D; Książyk J
    Pneumonol Alergol Pol; 2013; 81(5):448-52. PubMed ID: 23996884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutant fruit flies respond to Lorenzo's oil.
    Barinaga M
    Science; 1999 Jun; 284(5422):1899, 1901. PubMed ID: 10400528
    [No Abstract]   [Full Text] [Related]  

  • 37. Lorenzo's oil inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated very long-chain fatty acid.
    Sassa T; Wakashima T; Ohno Y; Kihara A
    J Lipid Res; 2014 Mar; 55(3):524-30. PubMed ID: 24489110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.
    Moser HW; Moser AB; Hollandsworth K; Brereton NH; Raymond GV
    J Mol Neurosci; 2007 Sep; 33(1):105-13. PubMed ID: 17901554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Komrower Lecture. Adrenoleukodystrophy: natural history, treatment and outcome.
    Moser HW
    J Inherit Metab Dis; 1995; 18(4):435-47. PubMed ID: 7494402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil).
    Rasmussen M; Moser AB; Borel J; Khangoora S; Moser HW
    Neurochem Res; 1994 Aug; 19(8):1073-82. PubMed ID: 7800117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.